Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) is anticipated to post its quarterly earnings results before the market opens on Tuesday, February 25th. Analysts expect Guardian Pharmacy Services to post earnings of $0.20 per share for the quarter.
Guardian Pharmacy Services Stock Performance
GRDN stock opened at $19.58 on Friday. Guardian Pharmacy Services has a fifty-two week low of $14.16 and a fifty-two week high of $25.74. The stock’s 50 day moving average price is $21.09.
Wall Street Analysts Forecast Growth
Separately, Truist Financial lifted their price objective on shares of Guardian Pharmacy Services from $22.00 to $24.00 and gave the stock a “buy” rating in a research report on Friday, November 15th.
About Guardian Pharmacy Services
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
Read More
- Five stocks we like better than Guardian Pharmacy Services
- Dividend Capture Strategy: What You Need to Know
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- The 3 Best Blue-Chip Stocks to Buy Now
- DuPont’s Electronics Spinoff: The Start of Something Big
- Bank Stocks – Best Bank Stocks to Invest In
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.
